nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—NR3C2—nephron—focal segmental glomerulosclerosis	0.125	0.458	CbGeAlD
Fludrocortisone—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0471	0.0842	CcSEcCtD
Fludrocortisone—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.0435	0.0778	CcSEcCtD
Fludrocortisone—Atrophy—Cyclosporine—focal segmental glomerulosclerosis	0.0425	0.0759	CcSEcCtD
Fludrocortisone—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0291	0.052	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.0284	0.175	CbGpPWpGaD
Fludrocortisone—NR3C2—nephron tubule—focal segmental glomerulosclerosis	0.027	0.0988	CbGeAlD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.0242	0.149	CbGpPWpGaD
Fludrocortisone—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0238	0.0426	CcSEcCtD
Fludrocortisone—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0238	0.0426	CcSEcCtD
Fludrocortisone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.0238	0.0426	CcSEcCtD
Fludrocortisone—NR3C2—kidney—focal segmental glomerulosclerosis	0.0237	0.0869	CbGeAlD
Fludrocortisone—NR3C2—cortex of kidney—focal segmental glomerulosclerosis	0.0231	0.0846	CbGeAlD
Fludrocortisone—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.0225	0.0402	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.0218	0.134	CbGpPWpGaD
Fludrocortisone—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0207	0.037	CcSEcCtD
Fludrocortisone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0197	0.0353	CcSEcCtD
Fludrocortisone—AR—kidney—focal segmental glomerulosclerosis	0.0176	0.0643	CbGeAlD
Fludrocortisone—AR—cortex of kidney—focal segmental glomerulosclerosis	0.0171	0.0626	CbGeAlD
Fludrocortisone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0282	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.0154	0.0944	CbGpPWpGaD
Fludrocortisone—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0145	0.026	CcSEcCtD
Fludrocortisone—NR3C1—nephron tubule—focal segmental glomerulosclerosis	0.0145	0.053	CbGeAlD
Fludrocortisone—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0235	CcSEcCtD
Fludrocortisone—NR3C1—kidney—focal segmental glomerulosclerosis	0.0127	0.0466	CbGeAlD
Fludrocortisone—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0226	CcSEcCtD
Fludrocortisone—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0224	CcSEcCtD
Fludrocortisone—NR3C1—cortex of kidney—focal segmental glomerulosclerosis	0.0124	0.0454	CbGeAlD
Fludrocortisone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0207	CcSEcCtD
Fludrocortisone—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0201	CcSEcCtD
Fludrocortisone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0195	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.0107	0.066	CbGpPWpGaD
Fludrocortisone—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0186	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0186	CcSEcCtD
Fludrocortisone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00989	0.0177	CcSEcCtD
Fludrocortisone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00952	0.017	CcSEcCtD
Fludrocortisone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00886	0.0158	CcSEcCtD
Fludrocortisone—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00874	0.0156	CcSEcCtD
Fludrocortisone—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00852	0.0152	CcSEcCtD
Fludrocortisone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00846	0.0151	CcSEcCtD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—PIAS1—focal segmental glomerulosclerosis	0.00834	0.0513	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00784	0.014	CcSEcCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00745	0.0458	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.0125	CcSEcCtD
Fludrocortisone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.0124	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—PIAS1—focal segmental glomerulosclerosis	0.00617	0.0379	CbGpPWpGaD
Fludrocortisone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00972	CcSEcCtD
Fludrocortisone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00524	0.00937	CcSEcCtD
Fludrocortisone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00934	CcSEcCtD
Fludrocortisone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00921	CcSEcCtD
Fludrocortisone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00883	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00883	CcSEcCtD
Fludrocortisone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00877	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00854	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00805	CcSEcCtD
Fludrocortisone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00799	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00404	0.0249	CbGpPWpGaD
Fludrocortisone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00701	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00651	CcSEcCtD
Fludrocortisone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00634	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.00335	0.0206	CbGpPWpGaD
Fludrocortisone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00553	CcSEcCtD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	0.00223	0.0137	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00221	0.0136	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—EDN1—focal segmental glomerulosclerosis	0.0021	0.0129	CbGpPWpGaD
Fludrocortisone—Dexamethasone—NOS2—focal segmental glomerulosclerosis	0.00209	0.453	CrCbGaD
Fludrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.00194	0.0119	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.00186	0.0114	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—AGT—focal segmental glomerulosclerosis	0.00174	0.0107	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.00162	0.00999	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—focal segmental glomerulosclerosis	0.00162	0.00995	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	0.00157	0.00966	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00124	0.00763	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—focal segmental glomerulosclerosis	0.00122	0.00748	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	0.00119	0.00733	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00112	0.00688	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.00106	0.00653	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—MMP9—focal segmental glomerulosclerosis	0.00103	0.00631	CbGpPWpGaD
Fludrocortisone—Prednisone—ALB—focal segmental glomerulosclerosis	0.00102	0.22	CrCbGaD
Fludrocortisone—Methyltestosterone—ALB—focal segmental glomerulosclerosis	0.000954	0.206	CrCbGaD
Fludrocortisone—NR3C2—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000894	0.0055	CbGpPWpGaD
Fludrocortisone—NR3C1—Endoderm Differentiation—TGFB1—focal segmental glomerulosclerosis	0.000865	0.00532	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000862	0.0053	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000847	0.00521	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	0.000846	0.0052	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000816	0.00502	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000654	0.00402	CbGpPWpGaD
Fludrocortisone—Testosterone—ALB—focal segmental glomerulosclerosis	0.000553	0.12	CrCbGaD
Fludrocortisone—NR3C1—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000515	0.00317	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000499	0.00307	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000415	0.00255	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000408	0.00251	CbGpPWpGaD
Fludrocortisone—AR—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.00242	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000315	0.00194	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000298	0.00183	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000189	0.00116	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	0.000144	0.000883	CbGpPWpGaD
